IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome

Conditions:   Myelodysplastic Syndromes;   Acute Myeloid Leukemia Intervention:   Drug: AG-120 Sponsor:   Groupe Francophone des Myelodysplasies Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials